![William Larkins](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
William C.
Larkins served as Chief Executive Officer & Director at CUSTOpharm, Inc. from 2015 to 2022.
Dr. Larkins served as President-Injectables Business at Hikma Pharmaceuticals Plc from 2023 to 2026.
Dr. Larkins earned a doctorate from The Ohio State University and completed undergraduate studies at Purdue University.
Anciens postes connus de William Larkins
| Sociétés | Poste | Fin |
|---|---|---|
| HIKMA PHARMACEUTICALS PLC | Corporate Officer/Principal | 01/01/2026 |
CUSTOpharm, Inc.
 CUSTOpharm, Inc. Pharmaceuticals: MajorHealth Technology Develops sterile injectable pharmaceutical products | Directeur Général | 01/09/2022 |
Formation de William Larkins
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
13
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Hikma Pharmaceuticals Plc
 Hikma Pharmaceuticals Plc Pharmaceuticals: GenericHealth Technology Develops, manufactures and markets branded and non-branded generic and in-licensed products | Health Technology |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Purdue University
 Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CUSTOpharm, Inc.
CUSTOpharm, Inc. Pharmaceuticals: MajorHealth Technology Develops sterile injectable pharmaceutical products | Health Technology |
